SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer. Zielske SP, Chen W, Ibrahim KG, Cackowski FC, et al. BMC Cancer 2023;23:672.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zielske SP, Chen W, Ibrahim KG, Cackowski FC, et al. SNHG1 opposes quiescence and promotes docetaxel sensitivity in prostate cancer. BMC Cancer 2023;23:672.
PMID: 37464317